Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
532. Hochstrasser B, Isaksen PM, Koponen H, Lauritzen L, Mahnert FA, Rouillon F, Wa<strong>de</strong> AG,<br />
An<strong>de</strong>rsen M, Pe<strong>de</strong>rsen SF, Swart JC, Nil R. Prophylactic effect of citalopram in unipolar,<br />
recurrent <strong>de</strong>pression: placebo-controlled study of maintenance therapy. Br J Psychiatry<br />
2001;178:304-10.<br />
533. Prien RF, Kupfer DJ. Continuation drug therapy for major <strong>de</strong>pressive episo<strong>de</strong>s: how long<br />
should it be maintained? Am J Psychiatry 1986;143(1):18-23.<br />
534. Prien RF. Efficacy of continuation drug therapy of <strong>de</strong>pression and anxiety: issues and<br />
methodologies. J Clin Psychopharmacol 1990;10:86-90.<br />
535. Hirschfeld RM. Clinical importance of long-term anti<strong>de</strong>pressant treatment. Br J Psychiatry<br />
Suppl 2001;42:S4-S8.<br />
536. Rouillon F, Phillips R, Serrurier D, Ansart E, Gerard MJ. Rechutes <strong>de</strong> <strong>de</strong>pression unipolaire et<br />
efficacite <strong>de</strong> la maprotiline. Encephale 1989;15(6):527-34.<br />
537. Greil W, Kleindienst N. Rezidivprophylaxe affektiver Störungen mit Lithium. In: Müller-<br />
Oerlinghausen B, Greil W, Berghofer A, editors. Die Lithiumtherapie. Berlin: Springer; 1997. p.<br />
190-218<br />
538. Reimherr FW, Amsterdam JD, Quitkin FM, Rosenbaum JF, Fava M, Zajecka J, Beasley CM,<br />
Jr., Michelson D, Roback P, Sun<strong>de</strong>ll K. Optimal length of continuation therapy in <strong>de</strong>pression: a<br />
prospective assessment during long-term fluoxetine treatment. Am J Psychiatry<br />
1998;155(9):1247-53.<br />
539. Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES,<br />
Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson<br />
JM, Schatzberg AF, Zajecka JM, Pe<strong>de</strong>rsen R, Yan B, Ahmed S, Schmidt M, Ninan PT. The<br />
Prevention of Recurrent Episo<strong>de</strong>s of <strong>Depression</strong> with Venlafaxine for Two Years (PREVENT)<br />
study: outcomes from the acute and continuation phases. Biol Psychiatry 2007;62(12):1371-9.<br />
540. Kocsis JH, Kornstein SG, Ahmed S, Ferdousi T, Musgnung J, Thase M, Friedman E, Dunlop<br />
BW, Yan B, Pe<strong>de</strong>rsen R, Ninan PT. Two years of maintenance treatment with venlafaxine xr<br />
75-225 mg/d: Efficacy in patients with recurrent unipolar major <strong>de</strong>pression. Eur Psychiatry<br />
2007;22(suppl. 1):S239-40.<br />
541. Montgomery SA, Huusom AK, Bothmer J. A randomised study comparing escitalopram with<br />
venlafaxine XR in primary care patients with major <strong>de</strong>pressive disor<strong>de</strong>r. Neuropsychobiology<br />
2004;50(1):57-64.<br />
542. Franchini L, Gasperini M, Perez J, Smeraldi E, Zanardi R. Dose-response efficacy of<br />
paroxetine in preventing <strong>de</strong>pressive recurrences: a randomized, double-blind study. J Clin<br />
Psychiatry 1998;59(5):229-32.<br />
543. Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ. World Fe<strong>de</strong>ration of Societies of<br />
Biological Psychiatry (WFSBP) Gui<strong>de</strong>lines for Biological Treatment of Unipolar Depressive<br />
Disor<strong>de</strong>rs, Part 2: Maintenance treatment of major <strong>de</strong>pressive disor<strong>de</strong>r and treatment of<br />
chronic <strong>de</strong>pressive disor<strong>de</strong>rs and subthreshold <strong>de</strong>pressions. World J Biol Psychiatry<br />
2002;3(2):69-86.<br />
544. Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar <strong>de</strong>pression: a metaanalysis.<br />
Br J Psychiatry 1991;158:666-75.<br />
545. Baethge C, Gruschka P, Smolka MN, Berghofer A, Bschor T, Müller-Oerlinghausen B, Bauer<br />
M. Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major<br />
<strong>de</strong>pressive disor<strong>de</strong>r. J Psychiatry Neurosci 2003;28(5):355-61.<br />
546. Burgess S, Ged<strong>de</strong>s J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for<br />
maintenance treatment of mood disor<strong>de</strong>rs. Cochrane Lib 2003;(2).<br />
547. Hammad TA, Laughren TP, Racoosin JA. Suici<strong>de</strong> rates in short-term randomized controlled<br />
trials of newer anti<strong>de</strong>pressants. J Clin Psychopharmacol 2006;26(2):203-7.<br />
548. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suici<strong>de</strong> risk in bipolar<br />
disor<strong>de</strong>r during treatment with lithium and divalproex. JAMA 2003;290(11):1467-73.<br />
549. Tondo L, Bal<strong>de</strong>ssarini RJ, Floris G, Rudas N. Effectiveness of restarting lithium treatment after<br />
its discontinuation in bipolar I and bipolar II disor<strong>de</strong>rs. Am J Psychiatry 1997;154(4):548-50.<br />
© 2009 228